Viewing Study NCT00095550


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-03-28 @ 4:00 AM
Study NCT ID: NCT00095550
Status: COMPLETED
Last Update Posted: 2011-04-15
First Post: 2004-11-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module